The influence of genetic polymorphisms of CYP3A on the pharmacokinetic variation and clinical outcomes of tacrolimus in a cohort of patients / Mohd Rahimi Muda
The complexity of determining the variability in tacrolimus pharmacokinetics parameter among organ transplant patients and its narrow therapeutic window characteristics necessitates proper drug monitoring in order to ensure the level is maintained within therapeutic range. Many studies have reported...
Main Author: | Muda, Mohd Rahimi |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | https://ir.uitm.edu.my/id/eprint/15160/2/15160.pdf |
Similar Items
-
Developing and validating a new comprehensive glucose-insulin pharmacokinetics and pharmacodynamics model
by: Ummu Kulthum, Jamaludin
Published: (2013) -
Statistical analysis of the nexus between dietary habits and practices with clinical outcome in Saudi patients with type 2 diabetes
by: Sami, Waqas
Published: (2019) -
CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
by: Ngow, Harris Abdullah, et al.
Published: (2009) -
Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010) -
ABCB1 genetic variants in leukemias: current insights into treatment outcomes
by: Ankathil, Ravindran
Published: (2017)